CareLit · DOI-Nachweis · Pneumologie
12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-suspension Delivery Technology in Patients with COPD
DOI 10.1055/s-0039-3403158
Bibliografische Angaben
Nachweis in CareLit
Autor:innenGT Ferguson, KF Rabe, E Bourne, S Ballal, K DeAngelis, M Aurivillius, C Reisner, P Dorinsky
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-suspension Delivery Technology in Patients with COPD
Zitieren
Zitierempfehlung
GT Ferguson, KF Rabe, E Bourne, S Ballal, K DeAngelis, M Aurivillius, C Reisner, P Dorinsky (2020) 12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-suspension Delivery Technology in Patients with COPD. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403158
Mit CareLit weiterarbeiten